The two companies are expanding their strategic collaboration with the integration of Azure OpenAI Service
The potential for AI to revolutionize medical education and practice means that it is set to have a significant impact on the healthcare industry...
As part of the deal, Vysioneer gains access to one of Pfizer's oncology clinical trial datasets to apply its machine learning techniques to facilitate the drug efficacy assessment process
The company's new privacy-preserving nSights platform accelerates the development of therapeutics and diagnostics for life sciences companies.
Called ORAiCLE, it can assess the cardiovascular risk of an individual through a retinal scan, more accurately than the current gold standard.
The platform brings $100 million in seed-stage funding and permanent long-term growth capital to systematically launch healthcare AI companies at scale.
This opens a new channel for proactive self-care health engagement for Higi's thousands of U.S. app users.
Diagnosing TB early is difficult because its symptoms can mimic those of common respiratory diseases.
It was designed to help users understand what's going on with issues related to the body's largest organ: their skin, hair and nails.
The results on 40,000+ mammograms showed that if Mia is introduced, the overall double reading recall rate is 4-5% and the cancer detection rate is 8.4 per 1000.